A new antibody developed by AstraZeneca has retained its effectiveness against a strain of the coronavirus outbreak, according to new research in the journal Lancet Infectious Diseases (NIAID). Scientists say they have tested positive for Covid-19.
Source: wallstreet-online.dePublished on 2021-12-16
Related news
- Blood clot risk found among men with prostate cancer
- Eni works with AWS to boost efficiency of geoscience workflows using the OSDU Data Platform
- PhonePe , NITI Aayog partner to launch fintech open hackathon
- Entity Framework Core 6 plans take shape
- PhonePe , NITI Aayog team up to launch fintech open hackathon
- Without the Moskva , Russia Black Sea fleet is far more exposed to missiles and drones
- New data hub invites companies to map global supply chains
- Westmoreland County adds fewest new covid cases since early October
- Pennsylvania covid cases down over 50 % in past month
- Empowering co - operation : united kingdom Co - op Congress 2022
- Blood clot risk found among men with prostate cancer | Isle of Wight County Press
- Blood clot risk found among men with prostate cancer | Somerset County Gazette
- Urban Brand - Utility : a protopia for effective marketing communications
- CoTech : IT collaboration to build new technology
- Congressional watchdog to study automotive right to repair issues